Teva Presents New Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets that Show Patient- and Caregiver-Reported Improvements in Huntington's Disease
katrina4384
Jun 9
1 min read
"Huntington’s disease (HD) is a neurological disorder that can impact an individual’s physical, mental and emotional functioning. About 90% of individuals with HD will develop chorea, the involuntary movements associated with HD, and we know its symptoms profoundly impact not only the individual, but also their family members and care partners.
New research presented at Advanced Therapeutics in Movement & Related Disorders (ATMRD) Congress highlights the significant impact of chorea on both those living with HD and their caregivers across various aspects of daily life including emotional and social wellbeing."
Learn more about these insights https://bit.ly/4dRUR9y
The patient- and caregiver-reported improvements in Huntington's disease really highlight how AUSTEDO XR is making a tangible difference in daily life, not just on a clinical scale. It's encouraging to see this focus on real-world experiences alongside the data. I've been following similar resources at https://faceless-video.net
The patient- and caregiver-reported improvements really highlight how meaningful symptom control can be beyond the clinical measures. It’s encouraging to see real-world impact being captured this way, especially for Huntington’s families navigating daily challenges. For more insights and community support, I’ve been following https://3mf-to-stl.org
The patient- and caregiver-reported improvements really highlight how meaningful the impact can be beyond the clinical measures—especially for daily quality of life in HD. I've been tracking this closely and appreciate the focus on real-world experiences, check out the full breakdown at https://yeggi.pro
The patient- and caregiver-reported improvements really highlight how meaningful the impact can be beyond the clinical measures. It’s encouraging to see this focus on daily living with HD. I’ve been following similar insights through https://glbviewer.com
The patient- and caregiver-reported improvements in Huntington’s disease really highlight how meaningful AUSTEDO XR’s extended-release option can be for daily routines. I’ve been tracking these updates closely, and this data gives me more hope for better symptom management—check out the full breakdown at https://framepack-ai.com